Search results
Prof Mariya Moosajee at Moorfields Eye Hospital has asked us to share the message below about the clinical trial she is running. This trial is for a treatment that targets a particular section of the USH2A gene.
Saturday 28 September 2024, 5pm - In-person meet up for food and drinks at the Pendulum Hotel Garden Bar & Restaurant following on from our Annual Conference.
Our community is informed and knowledgeable about current research projects into the cause(s) of and treatments for these conditions.
As part of our aim to nurture young scientists, we are very pleased to introduce one of our new PhD students as part of a co-funding agreement with the Macular Society.
Fundraising for Retina UK means a lot to me - both my dad and my nephew have been affected by inherited sight-loss, and I've seen first-hand the incredible work this charity does.
Retina UK is delighted that the Scottish Medicines Consortium (SMC) has accepted the gene therapy Luxturna (voretigene neparvovec) for ongoing use by the NHS in Scotland.
After more than 10 years of service as Chair of the Board of Trustees, Don Grocott has retired.
Next month, Anisha and Sheena will take on The Thames Path Challenge. Together, they explain why they decided to join #TeamRetinaUK.
Whether you're an expert runner, or a rebel *with* a cause, there's no better experience than the London Marathon!
Have you ever been tempted to take part in the TCS London Marathon? In 2022 the TCS London Marathon raised £58.3 million for charity so it’s a vital source of income.
